NeuroTherm receives US patent for RF generator

Sep 23 2009

NeuroTherm is pleased to be recognized by the United States Patent Office as the first company worldwide to develop and release a multiple output radiofrequency generator used in the treatment of chronic pain, ref. US Patent No. 7,574,257.

"This patent is a great honor and represents a major step forward in radiofrequency technology," says Bill Rittman, CTO of NeuroTherm. "The multi-lesion design has since become the standard for the interventional pain industry; we have come a long way in helping patients who suffer from chronic pain and the people who treat them, and I look forward to being a part of many more innovations at NeuroTherm," continues Rittman.

"NeuroTherm is proud to receive this milestone patent which is one great example of the many novel technologies we have developed to treat those suffering with chronic pain," says Larry Hicks, CEO of NeuroTherm. "Protection of our intellectual property is also vital to maintaining our leadership," continues Hicks.